Heartflow Q2 revenue rises 48%, lifts 2026 outlook
Heartflow Q2 revenue rises 48%, lifts 2026 outlook
Overview
U.S. AI cardiovascular diagnostics firm's Q2 revenue rose 48% yr/yr on higher case volumes
Company posted record gross margin of 83.0%, up from 75.5% a year ago
Heartflow raised 2026 revenue guidance to 40-42% growth from prior 29-32% forecast
Outlook
Heartflow raises 2026 revenue guidance to $246 mln-$250 mln from $228 mln-$232 mln
Company lifts 2026 non-GAAP gross margin outlook to about 82% from about 81%
Heartflow says CCTA market remains under-penetrated, supporting expectations for continued growth
Result Drivers
U.S. CASE VOLUME - Co said year-over-year revenue growth was primarily driven by higher total U.S. FFR(CT) and Plaque revenue case volumes
AI EFFICIENCY - Gross margin expansion attributed to increased case volume, higher U.S. Plaque revenue, and improved production team productivity from AI efficiency initiatives
HIGHER OPERATING EXPENSES - Increase in operating expenses due to greater investment in sales personnel, technology, and clinical research
Company press release: ID:nGNX9LLMbR
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Revenue |
| $64.08 mln |
|
Q2 Net Loss |
| $15.74 mln |
|
Q2 Gross Profit |
| $53.19 mln |
|
Q2 Income from Operations |
| -$17.9 mln |
|
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"
Wall Street's median 12-month price target for Heartflow, Inc. is $37.00, about 24% above its August 12 closing price of $29.85
Reuters Recommended Reads
Aug 13 - Singapore's AsiaMedic HY loss narrows sharply on diagnostic imaging growth
Aug 12 - Canada's HLS Therapeutics Q2 revenue rises on higher cardiovascular drugs demand
Aug 12 - Definium says LSD-based pill reduces anxiety in late-stage study
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)